Ignite Creation Date:
2025-12-24 @ 9:28 PM
Ignite Modification Date:
2025-12-25 @ 7:14 PM
Study NCT ID:
NCT03436732
Status:
TERMINATED
Last Update Posted:
2019-11-22
First Post:
2018-02-16
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-02-28
Start Date Type:
ACTUAL
Primary Completion Date:
2019-04-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-04-30
Completion Date Type:
ACTUAL
First Submit Date:
2018-02-16
First Submit QC Date:
None
Study First Post Date:
2018-02-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2019-09-23
Results First Submit QC Date:
None
Results First Post Date:
2019-11-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-04
Last Update Post Date:
2019-11-22
Last Update Post Date Type:
ACTUAL